AU2002220082A1 - Imaging of enzymatic activity - Google Patents
Imaging of enzymatic activityInfo
- Publication number
- AU2002220082A1 AU2002220082A1 AU2002220082A AU2008202A AU2002220082A1 AU 2002220082 A1 AU2002220082 A1 AU 2002220082A1 AU 2002220082 A AU2002220082 A AU 2002220082A AU 2008202 A AU2008202 A AU 2008202A AU 2002220082 A1 AU2002220082 A1 AU 2002220082A1
- Authority
- AU
- Australia
- Prior art keywords
- imaging
- enzymatic activity
- enzymatic
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24156600P | 2000-10-19 | 2000-10-19 | |
US60/241,566 | 2000-10-19 | ||
US31033501P | 2001-08-06 | 2001-08-06 | |
US60/310,335 | 2001-08-06 | ||
PCT/US2001/045532 WO2002032291A2 (en) | 2000-10-19 | 2001-10-19 | Imaging of enzymatic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002220082A1 true AU2002220082A1 (en) | 2002-04-29 |
Family
ID=26934397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002220082A Abandoned AU2002220082A1 (en) | 2000-10-19 | 2001-10-19 | Imaging of enzymatic activity |
Country Status (6)
Country | Link |
---|---|
US (2) | US6737247B2 (en) |
EP (1) | EP1326523A4 (en) |
JP (1) | JP2004530408A (en) |
AU (1) | AU2002220082A1 (en) |
CA (1) | CA2425873A1 (en) |
WO (1) | WO2002032291A2 (en) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6875864B2 (en) * | 1991-08-01 | 2005-04-05 | Bracco International B.V. | Aminocarboxylate ligands having substituted aromatic amide moieties |
US7067111B1 (en) | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
EP1286704B1 (en) * | 2000-06-02 | 2014-07-23 | Board of Regents, The University of Texas System | ETHYLENEDICYSTEINE (EC)-glucose analog CONJUGATES |
BR0316046A (en) | 2002-11-07 | 2005-09-13 | Univ Texas | Drug and ethylenodicysteine (ec) conjugates, compositions and methods for imaging tissue specific disease |
US7431915B2 (en) | 2003-10-31 | 2008-10-07 | The Regents Of The University Of California | Peptides whose uptake by cells is controllable |
US7985401B2 (en) | 2003-10-31 | 2011-07-26 | The Regents Of The University Of California | Peptides whose uptake by cells is controllable |
US9695251B2 (en) | 2003-10-31 | 2017-07-04 | The Regents Of The University Of California | Activatable cell penetrating peptides with quenched fluorophores |
US9050378B2 (en) * | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
US8153784B2 (en) * | 2004-07-07 | 2012-04-10 | The General Hospital Corporation | Imaging of enzyme activity |
US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
US8758723B2 (en) | 2006-04-19 | 2014-06-24 | The Board Of Regents Of The University Of Texas System | Compositions and methods for cellular imaging and therapy |
JP5864077B2 (en) | 2006-09-08 | 2016-02-17 | ロード アイランド ホスピタル | Treatment, prevention and recovery of alcohol-induced liver disease |
JP2010502719A (en) | 2006-09-08 | 2010-01-28 | ロード アイランド ホスピタル | Treatment, prevention and recovery of alcohol-induced brain disease |
US10925977B2 (en) | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
US20100104511A1 (en) * | 2006-11-22 | 2010-04-29 | The Board Of Regents Of The University Of Texas System | Methods and compositions using chelator-antibody conjugates |
CA2682064C (en) | 2007-03-27 | 2013-09-24 | Radiomedix Inc. | Compositions for targeted imaging and therapy |
DE102007039899B3 (en) * | 2007-08-23 | 2009-04-09 | Siemens Ag | Sensor for enabling the detection of a substance in the body of a living being |
US8111809B2 (en) | 2009-01-29 | 2012-02-07 | The Invention Science Fund I, Llc | Diagnostic delivery service |
US8130904B2 (en) | 2009-01-29 | 2012-03-06 | The Invention Science Fund I, Llc | Diagnostic delivery service |
US9155471B2 (en) | 2009-05-27 | 2015-10-13 | Lumicell, Inc'. | Methods and systems for spatially identifying abnormal cells |
WO2010138738A1 (en) | 2009-05-27 | 2010-12-02 | Lumicell Diagnostics, Inc. | Methods and systems for spatially identifying abnormal cells |
EP2454271A4 (en) * | 2009-07-15 | 2015-08-12 | Univ California | Peptides whose uptake in cells is controllable |
US9314304B2 (en) | 2010-12-08 | 2016-04-19 | Lumicell, Inc. | Methods and system for image guided cell ablation with microscopic resolution |
WO2012159107A1 (en) | 2011-05-19 | 2012-11-22 | Rhode Island Hospital | Inhibition of renal fibrosis |
DK2721045T3 (en) | 2011-06-20 | 2017-07-24 | Radiomedix Inc | COMPOSITIONS, METHODS OF SYNTHESIS AND USE OF CARBOHYDRATE TARGETED AGENTS |
US20150297761A1 (en) * | 2012-11-12 | 2015-10-22 | The General Hospital Corporation | Peptidic structures incorporating an amino acid metal complex and applications in magnetic resonance imaging |
US10029017B2 (en) | 2013-01-29 | 2018-07-24 | The Regents Of The University Of California | Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug |
US9782498B2 (en) | 2013-01-30 | 2017-10-10 | Avelas Biosciences, Inc. | Selective delivery molecules and methods of use |
AU2014236561B2 (en) | 2013-03-14 | 2018-08-16 | Lumicell, Inc. | Medical imaging device and methods of use |
WO2015099094A1 (en) | 2013-12-27 | 2015-07-02 | 国立大学法人東京医科歯科大学 | Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents |
US10385380B2 (en) | 2014-10-02 | 2019-08-20 | The Regents Of The University Of California | Personalized protease assay to measure protease activity in neoplasms |
US10596259B2 (en) | 2015-05-20 | 2020-03-24 | The Regents Of The University Of California | Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof |
CN110577553B (en) * | 2018-06-11 | 2021-09-21 | 天津师范大学 | Synthetic method and application of three-dimensional porous complex based on six-core terbium cluster |
KR102323277B1 (en) * | 2019-12-02 | 2021-11-08 | 경북대학교 산학협력단 | Novel gadolinium-based compound, pharmaceutical composition for treating or preventing inflammatory disease comprising the same, and mri contrast composition |
WO2021150052A1 (en) * | 2020-01-22 | 2021-07-29 | 경북대학교 산학협력단 | Novel gadolinium-based compound, preparation method therefor, and mri contrast agent containing same |
EP4095142A4 (en) * | 2020-01-22 | 2024-01-17 | Kyungpook Nat Univ Ind Academic Coop Found | Novel gadolinium-based compound, preparation method therefor, and mri contrast agent containing same |
WO2021150049A1 (en) * | 2020-01-22 | 2021-07-29 | 경북대학교 산학협력단 | Novel gadolinium-based compound, method for producing same, and mri contrast agent containing same |
CN115279772A (en) * | 2020-01-22 | 2022-11-01 | 庆北大学校产学协力团 | Novel gadolinium-based compound, preparation method thereof, and MRI contrast agent containing the same |
WO2023003411A1 (en) * | 2021-07-21 | 2023-01-26 | 경북대학교 산학협력단 | Gadolinium-based compound and mri contrast agent comprising same |
WO2023003413A1 (en) * | 2021-07-21 | 2023-01-26 | 주식회사 테라노큐어 | Gadolinium-based compound, and mri contrast agent including same |
WO2023003412A1 (en) * | 2021-07-21 | 2023-01-26 | 경북대학교 산학협력단 | Gadolinium-based compound, and mri contrast agent including same |
KR102659248B1 (en) | 2021-07-21 | 2024-04-19 | 경북대학교 산학협력단 | Gadolinium-based compound, mri contrast agent comprising the same |
KR102659253B1 (en) | 2021-12-03 | 2024-04-19 | 경북대학교 산학협력단 | Gadolinium-based compound, mri contrast agent comprising the same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5482700A (en) | 1987-03-31 | 1996-01-09 | Schering Aktiengesellschaft | Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast |
US5446145A (en) * | 1990-01-19 | 1995-08-29 | Nycomed Salutar, Inc. | Polychelant compounds |
GB8927503D0 (en) * | 1989-12-04 | 1990-02-07 | Kronem Systems Inc | Enzyme-amplified lanthanide chelate luminescence |
US5254460A (en) | 1990-05-03 | 1993-10-19 | Advanced Magnetics, Inc. | Solvent mediated relaxation assay system |
US5559214A (en) * | 1993-05-28 | 1996-09-24 | Sterling Winthrop Inc. | Unsymmetrical complexing agents and targeting immunoreagents useful in thearpeutic and diagnostic compositions and methods |
IT1274038B (en) * | 1994-07-29 | 1997-07-14 | Bracco Spa | MACROCYCLIC CHELANTS THEIR CHELATES AND RELATED USES IN THE DIAGNOSTIC FIELD |
US5707605A (en) * | 1995-06-02 | 1998-01-13 | Research Corporation Technologies | Magnetic resonance imaging agents for the detection of physiological agents |
US5980862A (en) | 1995-06-02 | 1999-11-09 | Research Corporation Technologies | Magnetic resonance imaging agents for the detection of physiological agents |
AU7066698A (en) * | 1997-04-22 | 1998-11-13 | Nycomed Imaging As | Nmr image compounds |
-
2001
- 2001-10-19 JP JP2002535534A patent/JP2004530408A/en active Pending
- 2001-10-19 US US09/999,665 patent/US6737247B2/en not_active Expired - Fee Related
- 2001-10-19 CA CA002425873A patent/CA2425873A1/en not_active Abandoned
- 2001-10-19 AU AU2002220082A patent/AU2002220082A1/en not_active Abandoned
- 2001-10-19 EP EP01987638A patent/EP1326523A4/en not_active Withdrawn
- 2001-10-19 WO PCT/US2001/045532 patent/WO2002032291A2/en not_active Application Discontinuation
-
2004
- 2004-04-30 US US10/837,504 patent/US20040241096A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002032291A2 (en) | 2002-04-25 |
WO2002032291A3 (en) | 2003-02-06 |
EP1326523A2 (en) | 2003-07-16 |
US20040241096A1 (en) | 2004-12-02 |
JP2004530408A (en) | 2004-10-07 |
EP1326523A4 (en) | 2005-01-05 |
US20020127629A1 (en) | 2002-09-12 |
WO2002032291A9 (en) | 2003-04-17 |
US6737247B2 (en) | 2004-05-18 |
CA2425873A1 (en) | 2002-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002220082A1 (en) | Imaging of enzymatic activity | |
AU3867400A (en) | Methods of using bioelastomers | |
AU2002320185A1 (en) | Biological activity of ak155 | |
AU6364700A (en) | Human synthetases | |
AU2001227815A1 (en) | Chemically specific imaging of tissue | |
AU2001267333A1 (en) | Lipolytic enzyme | |
AU1878601A (en) | Enzyme | |
AU2002357860A1 (en) | Enzymes | |
AU2001268683A1 (en) | Modification of mdm2 activity | |
AU2001233208A1 (en) | Human sulfatases | |
IL135466A0 (en) | Enzymatic modification of sterols | |
AU2576100A (en) | Novel enzyme | |
AU3388400A (en) | Human glycosylation enzymes | |
AU6949200A (en) | Human hydrolytic enzymes | |
AU2001263850A1 (en) | Pyrimidine-sulfonamides having endothelin-antagonist activity | |
AU2002347778A1 (en) | Enzymes | |
AU2982000A (en) | Preparation of 9-hydrocarbyl-9-phosphabicyclononanes | |
AU2002250041A1 (en) | Putative human enzymes | |
AU2001256773A1 (en) | Regulation of mt1-mmp activity | |
AU2001260467A1 (en) | Integrin-targeting vectors having enhanced transfection activity | |
AU2001281950A1 (en) | Regulation of human thimet oligopeptidase-like enzyme | |
AU7711800A (en) | Novel uses of 2-bromopalmitate | |
AU2001274080A1 (en) | Regulation of human transketolase-like enzyme | |
AU4367900A (en) | Carbohydrate-modifying enzymes | |
AUPR673001A0 (en) | Pregnancy-related enzyme activity |